GlassScriptPhysician profile
Michael R Redler
NPI 1215960067
$762,558.67
in general payments reported to CMS, 2019-2025
29 companies · $249K in 2025
The $249K reported for 2025 was more than what 99% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133K · 2020: $25K · 2021: $59K · 2022: $53K · 2023: $55K · 2024: $189K · 2025: $249K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300K · Consulting Fee: $116K · Travel and Lodging: $61K · Food and Beverage: $8,853 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,630 · Royalty Or License: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300,181.00 |
| Consulting Fee | $115,872.75 |
| Travel and Lodging | $60,730.70 |
| Food and Beverage | $8,852.93 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,630.33 |
| Royalty Or License | $298.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $604,931.85 | 2019-2025 | Exogen Ultrasound Bone Healing System, Durolane, Durolane |
| Medical Device Business Services, INC. | $75,318.32 | 2019-2025 | Orthovisc, Peak, Monovisc |
| Linvatec Corporation | $55,844.67 | 2023-2025 | Biobrace 23mm, Linvatec Arthroscopy, Allograft Tissue |
| Geistlich Pharma, North America, INC. | $7,350.00 | 2025 | |
| Biorez, INC. | $5,000.00 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $4,280.81 | 2019-2023 | Exparel, Iovera, Zilretta |
| Acelrx Pharmaceuticals, INC. | $2,014.26 | 2019-2021 | |
| Depuy Synthes Sales INC. | $1,684.70 | 2019-2025 | Healix Knotless Peek, Vapr, Megadyne |
| Depuy Synthes Products, INC. | $1,260.00 | 2025 | |
| Buxton Biomedical | $1,214.22 | 2019-2025 | Hand Held Orthopedic Forcep/Clamp, Hand Held Orthopedic Forcep/Clamp, Forcep/Clamp |
| Arthrex, INC. | $1,165.71 | 2019 | |
| Conmed Corporation | $771.70 | 2024-2025 | Biobrace 23mm, Visiclear |
| Smith+Nephew, INC. | $349.37 | 2019-2025 | Spatial Frame, Firstpass, Na |
| Miach Orthopaedics, INC. | $299.35 | 2024-2025 | |
| Anika Therapeutics, INC. | $221.10 | 2024 | Integrity |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $170.52 | 2022-2025 | Maci |
| Pacira Therapeutics, INC. | $138.53 | 2019-2020 | |
| Brixton Biosciences, INC. | $123.02 | 2024 | Neural Ice |
| Trice Medical, INC. | $102.45 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $58.39 | 2025 | |
| Endo Pharmaceuticals INC. | $54.35 | 2019-2023 | Xiaflex |
| Ermi LLC | $47.48 | 2025 | |
| Medline Industries LP | $40.56 | 2019 | |
| Baudax Bio INC. | $32.29 | 2021-2022 | |
| Orthofix Medical, INC. | $27.32 | 2024 | Accelstim, Physio-Stim |
| Innovation Technologies INC | $16.43 | 2025 | Irrisept |
| Endo USA, INC. | $15.34 | 2024 | Xiaflex |
| Sanofi-Aventis U.S. LLC | $13.38 | 2019 | |
| Horizon Therapeutics Plc | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Redler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.